Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Almirall SA (GB:0O9B)
LSE:0O9B
Holding GB:0O9B?
Track your performance easily
0O9B Stock Chart & Stats
Day’s Range€0 - €0
52-Week Range€7.77 - €9.97
Previous Close€8.41
Volume276.00
Average Volume (3M)21.84K
Market Cap
€1.79B
Enterprise Value€1.96B
Total Cash (Recent Filing)€224.94M
Total Debt (Recent Filing)€391.35M
Price to Earnings (P/E)―
Beta0.60
Next Earnings
Feb 24, 2025EPS Estimate
€0.09Last Dividend Ex-Date
May 17, 2024Dividend Yield1.81%
Share Statistics
EPS (TTM)-0.17
Shares OutstandingN/A
10 Day Avg. Volume1,205
30 Day Avg. Volume21,840
Standard Deviation0.08
R-Squared0.21
Alpha-0.00879
Financial Highlights & Ratios
Price to Book (P/B)0.00
Price to Sales (P/S)1.97
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€12.45Price Target Upside46.73% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
Almirall News
PremiumCompany Announcements
Almirall to Present 9-Month 2024 Financial Results
PremiumCompany Announcements
Almirall’s Lebrikizumab Shows Long-Term Efficacy
PremiumCompany Announcements
Almirall to Discuss H1 2024 Results in Live Webcast
PremiumCompany Announcements
Almirall Issues Cautious Financial Outlook Update
PremiumCompany Announcements
Almirall S.A. Reports Active Q2 TradingPremiumPre-Earnings
Is 0O9B a Buy, Before Earnings?Options Prices
Currently, No data available
---
Ownership Overview
―
Insiders
2.56% Mutual Funds
0.15% Other Institutional Investors
95.58% Public Companies and
Individual Investors
0O9B FAQ
What was Almirall SA’s price range in the past 12 months?
Almirall SA lowest share price was €7.76 and its highest was €9.97 in the past 12 months.
What is Almirall SA’s market cap?
Currently, no data Available
When is Almirall SA’s upcoming earnings report date?
Almirall SA’s upcoming earnings report date is Feb 24, 2025 which is in 102 days.
How were Almirall SA’s earnings last quarter?
Almirall SA released its earnings results on Nov 11, 2024. The company reported €0.11 earnings per share for the quarter, the consensus estimate of €0.11 by €0.
Is Almirall SA overvalued?
According to Wall Street analysts Almirall SA’s price is currently Undervalued.
Does Almirall SA pay dividends?
Almirall SA pays a Annually dividend of €0.15 which represents an annual dividend yield of 1.81%. See more information on Almirall SA dividends here
What is Almirall SA’s EPS estimate?
Almirall SA’s EPS estimate is €0.09.
How many shares outstanding does Almirall SA have?
Almirall SA has 213,468,720 shares outstanding.
What happened to Almirall SA’s price movement after its last earnings report?
Almirall SA reported an EPS of €0.11 in its last earnings report, expectations of €0.11. Following the earnings report the stock price went down -6.036%.
Which hedge fund is a major shareholder of Almirall SA?
Currently, no hedge funds are holding shares in GB:0O9B
---
Almirall Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
€12.45 (46.73% Upside)
€12.45 (46.73% Upside)
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
0.82%
12-Months-Change
Fundamentals
Return on Equity
-2.33%
Trailing 12-Months
Asset Growth
-0.79%
Trailing 12-Months
Company Description
Almirall SA
Almirall SA is a Spain-based company engaged in development, manufacture, and selling pharmaceutical products across a range of therapeutic areas. It aims to provide treatments in areas of dermatology, respiratory, gastrointestinal, central nervous systems, and other specialties. The company operates in five segments: Sales of its own network, sales of licensees, Research and developments, Sales of Therapeutic dermatological products in the U.S., and Corporate management. The medical dermatology business in the Europe is the key driver of the company's operation. Other than Europe, the company also operates in the Americas, Asia, Africa, and Oceania through subsidiaries.
---
0O9B Stock 12 Month Forecast
Average Price Target
€12.45
▲(46.73% Upside)
Technical Analysis
Best Analysts Covering 0O9B
1 Year
1 Year Success Rate
11/32 ratings generated profit
1 Year Average Return
-4.65%
reiterated a buy rating 3 days ago
Copying Pablo de Renteria's trades and holding each position for 1 Year would result in 34.38% of your transactions generating a profit, with an average return of -4.65% per trade.
---